Northern Trust Corp Olema Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 389,734 shares of OLMA stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

389,734

Previous 344,082 13.27%

Holding current value

$2.46 Million

Previous $3.72 Million 25.01%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.41 - $16.46 $475,237 - $751,431	45,652 Added 13.27%	389,734 $4.65 Million
Q2 2024 Aug 14, 2024	SELL	$8.73 - $13.99 $44,304 - $70,999	-5,075 Reduced 1.45%	344,082 $3.72 Million
Q1 2024 May 14, 2024	SELL	$10.95 - $16.62 $40,087 - $60,845	-3,661 Reduced 1.04%	349,157 $3.95 Million
Q4 2023 Feb 13, 2024	BUY	$10.53 - $17.14 $542,221 - $882,590	51,493 Added 17.09%	352,818 $4.95 Million
Q3 2023 Nov 13, 2023	BUY	$8.19 - $12.98 $53,800 - $85,265	6,569 Added 2.23%	301,325 $3.72 Million
Q2 2023 Aug 11, 2023	BUY	$3.22 - $9.65 $714,080 - $2.14 Million	221,764 Added 303.82%	294,756 $2.66 Million
Q1 2023 May 15, 2023	BUY	$2.55 - $4.97 $13,703 - $26,708	5,374 Added 7.95%	72,992 $253,000
Q4 2022 Feb 13, 2023	SELL	$2.27 - $3.76 $265 - $439	-117 Reduced 0.17%	67,618 $165,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.88 $20,495 - $44,305	7,535 Added 12.52%	67,735 $187,000
Q2 2022 Aug 12, 2022	SELL	$2.04 - $4.61 $348,193 - $786,848	-170,683 Reduced 73.93%	60,200 $245,000
Q1 2022 May 13, 2022	SELL	$3.89 - $9.43 $78,675 - $190,721	-20,225 Reduced 8.05%	230,883 $983,000
Q4 2021 Feb 08, 2022	BUY	$8.75 - $30.71 $42,376 - $148,728	4,843 Added 1.97%	251,108 $2.35 Million
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $2.59 Million - $3.4 Million	112,823 Added 84.55%	246,265 $6.79 Million
Q2 2021 Aug 13, 2021	BUY	$21.15 - $36.14 $70,514 - $120,490	3,334 Added 2.56%	133,442 $3.73 Million
Q1 2021 May 12, 2021	BUY	$27.81 - $53.64 $3.23 Million - $6.23 Million	116,206 Added 835.89%	130,108 $4.32 Million
Q4 2020 Feb 11, 2021	BUY	$37.09 - $54.5 $515,625 - $757,659	13,902 New	13,902 $668,000

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

58.7M

Call Options Held

141K

Put Options Held

23.1K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $255M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Olema Pharmaceuticals, Inc. Transaction History